When activated, these tyrosine kinase receptors will activate either the PI3K/AKT/mTOR signaling pathway or the RAS/mitogen-activated protein kinase /extracellular signal-regulated kinase (RAS/MEK/ERK) pathway to increase the production of HIFs, thereby accelerating the growth of the tumor [139]. The gene discussed is AKT1; the disease is neoplasm.